Integrated BioPharma Inc (INBP) KPIs and segments
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Integrated BioPharma's business
Integrated BioPharma's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Integrated BioPharma's fiscal year ends June 30 — Q4 FY26 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Contract Manufacturing($M)2 | 9.48 | 9.82 | 10.9 | 12.2 | 13.6 | 13.5 | 11.7 | 13.0 | 12.3 | 12.8 | 11.1 | 12.4 | |
United States($M) | 7.40 | 7.87 | 8.35 | 10.1 | 10.6 | 10.2 | 9.32 | 10.8 | 9.60 | 10.8 | 9.42 | 10.8 | |
Non-US($M) | 2.07 | 1.96 | 2.58 | 2.04 | 2.96 | 3.23 | 2.36 | 2.19 | 2.73 | 1.98 | 1.63 | 1.61 | |
Other Nutraceutical Business($M)2 | 0.32 | 0.28 | 0.36 | 0.52 | 0.60 | 0.49 | 0.94 | 0.64 | 0.42 | 0.40 | 0.46 | 0.48 | |
United States($M) | 0.32 | 0.28 | 0.36 | 0.52 | 0.60 | 0.49 | 0.94 | 0.64 | 0.42 | 0.40 | 0.43 | 0.48 | |
Non-US($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | |
United States($M) | 7.72 | 8.15 | 8.71 | 10.7 | 11.2 | 10.7 | 10.3 | 11.4 | 10.0 | 11.2 | 9.85 | 11.3 | |
Non-US($M) | 2.07 | 2.00 | 2.58 | 2.04 | 2.96 | 3.23 | 2.36 | 2.19 | 2.73 | 1.98 | 1.66 | 1.61 | |
Europe($M) | 1.96 | 2.58 | 2.04 | 3.23 | 2.36 | 2.19 | 1.98 | 1.66 | 1.61 | ||||
Earlier reporting (last reported 2023)1 | |||||||||||||
Contract Manufacturing($M) | 0.07 | -0.19 | 0.02 | 0.97 | 1.35 | 1.52 | 0.80 | 1.18 | 1.14 | 1.25 | 0.50 | 0.81 | |
Other Nutraceutical Business($M) | -0.04 | -0.08 | 0.01 | 0.05 | 0.12 | 0.03 | 0.37 | 0.19 | 0.15 | -0.00 | 0.02 | 0.02 | |
Other Nutraceutical Business($M) | 0 | 0 | -0.01 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00 | |
Contract Manufacturing($M) | -0.15 | 0 | -0.02 | -0.17 | -0.00 | -0.12 | -0.03 | -0.06 | -0.15 | -0.35 | -0.02 | -0.04 | |
Contract Manufacturing($M) | 21.8 | 22.4 | 18.9 | 21.1 | 20.3 | 19.9 | 19.6 | 20.8 | 20.8 | 21.1 | 19.5 | 20.5 | |
Other Nutraceutical Business($M) | 3.51 | 4.32 | 4.63 | 4.41 | 4.62 | 5.78 | 6.09 | 5.43 | 5.38 | 5.85 | 6.23 | 6.19 | |
14 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-09-25.
See a number that looks wrong?